For patients with chronic kidney disease (CKD), severity of CKD is associated with an increased incidence of cognitive ...

Rybrevant Faspro is a subcutaneous co-formulation of amivantamab, a bispecific EGFR-directed and MET receptor-directed antibody, and hyaluronidase.

A total of 340 biopsy-confirmed IgAN patients were randomised to daily oral Vanrafia or a placebo for approximately 132 weeks ...

At any given time almost 90,000 people in the United States are waiting for a kidney transplant, and every day 11 die waiting for one. Of these people, 35% are Black patients receiving dialysis for ...

On Friday, Novartis AG NVS shared final results from the Phase 3 ALIGN study supporting a slowing decline in kidney function in adults with IgA nephropathy (IgAN) who were treated with Vanrafia ...

In ALIGN study, Vanrafia (atrasentan) showed positive difference in eGFR change from baseline vs. placebo at Week 136, 4 weeks after study treatment ended1Results favored Vanrafia across multiple ...

Kidneys work quietly in the background, filtering waste, balancing fluids, and maintaining chemical stability without demanding attention. But this is until som ...

Kidney problems never or rarely announce themselves loudly. There is no sudden pain or obvious warning in the early stages, ...

In unadjusted analysis, rates of DKA among individuals with an eGFR between 30 and 90 mL/min/1.73 m 2 showed no statistical difference compared with those with an eGFR between 90 and 120 mL/min/1.73 m ...

Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...

MediBeacon ® Transdermal GFR System is a first-in-kind product for point of care kidney function assessment Centers of Excellence ...